Characterization of PLAC® tests in the quantization of lipoprotein associated phospholipase A2 for assessment of cardiovascular diseases
Keywords: ApoA1; apolipoprotein A1; ApoB; apolipoprotein B; BMI; body mass index; CHAPS; 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate; IHD; ischemic heart disease; Lp-PLA2; lipoprotein associated phospholipase A2; PAF; platelet-activating facto